Cargando…
Development of an activity disease score in patients with uveitis (UVEDAI)
To develop a disease activity index for patients with uveitis (UVEDAI) encompassing the relevant domains of disease activity considered important among experts in this field. The steps for designing UVEDAI were: (a) Defining the construct and establishing the domains through a formal judgment of exp...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357298/ https://www.ncbi.nlm.nih.gov/pubmed/27815703 http://dx.doi.org/10.1007/s00296-016-3593-1 |
_version_ | 1782516007336673280 |
---|---|
author | Pato, Esperanza Martin-Martinez, Mª Auxiliadora Castelló, Adela Méndez-Fernandez, Rosalía Muñoz-Fernández, Santiago Cordero-Coma, Miguel Martinez-Costa, Lucia Valls, Elia Reyes, Miguel Francisco, Félix Esteban, Mar Fonollosa, Alex Sanchez-Alonso, Fernando Fernández-Espartero, Cruz Diaz-Valle, Teresa Carrasco, José Miguel Beltran-Catalán, Emma Hernández-Garfella, Marisa Hernández, María Victoria Pelegrin, Laura Blanco, Ricardo Diaz-Valle, David |
author_facet | Pato, Esperanza Martin-Martinez, Mª Auxiliadora Castelló, Adela Méndez-Fernandez, Rosalía Muñoz-Fernández, Santiago Cordero-Coma, Miguel Martinez-Costa, Lucia Valls, Elia Reyes, Miguel Francisco, Félix Esteban, Mar Fonollosa, Alex Sanchez-Alonso, Fernando Fernández-Espartero, Cruz Diaz-Valle, Teresa Carrasco, José Miguel Beltran-Catalán, Emma Hernández-Garfella, Marisa Hernández, María Victoria Pelegrin, Laura Blanco, Ricardo Diaz-Valle, David |
author_sort | Pato, Esperanza |
collection | PubMed |
description | To develop a disease activity index for patients with uveitis (UVEDAI) encompassing the relevant domains of disease activity considered important among experts in this field. The steps for designing UVEDAI were: (a) Defining the construct and establishing the domains through a formal judgment of experts, (b) A two-round Delphi study with a panel of 15 experts to determine the relevant items, (c) Selection of items: A logistic regression model was developed that set ocular inflammatory activity as the dependent variable. The construct “uveitis inflammatory activity” was defined as any intraocular inflammation that included external structures (cornea) in addition to uvea. Seven domains and 15 items were identified: best-corrected visual acuity, inflammation of the anterior chamber (anterior chamber cells, hypopyon, the presence of fibrin, active posterior keratic precipitates and iris nodules), intraocular pressure, inflammation of the vitreous cavity (vitreous haze, snowballs and snowbanks), central macular edema, inflammation of the posterior pole (the presence and number of choroidal/retinal lesions, vascular inflammation and papillitis), and global assessment from both (patient and physician). From all the variables studied in the multivariate model, anterior chamber cell grade, vitreous haze, central macular edema, inflammatory vessel sheathing, papillitis, choroidal/retinal lesions and patient evaluation were included in UVEDAI. UVEDAI is an index designed to assess the global ocular inflammatory activity in patients with uveitis. It might prove worthwhile to motorize the activity of this extraarticular manifestation of some rheumatic diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00296-016-3593-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5357298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-53572982017-03-30 Development of an activity disease score in patients with uveitis (UVEDAI) Pato, Esperanza Martin-Martinez, Mª Auxiliadora Castelló, Adela Méndez-Fernandez, Rosalía Muñoz-Fernández, Santiago Cordero-Coma, Miguel Martinez-Costa, Lucia Valls, Elia Reyes, Miguel Francisco, Félix Esteban, Mar Fonollosa, Alex Sanchez-Alonso, Fernando Fernández-Espartero, Cruz Diaz-Valle, Teresa Carrasco, José Miguel Beltran-Catalán, Emma Hernández-Garfella, Marisa Hernández, María Victoria Pelegrin, Laura Blanco, Ricardo Diaz-Valle, David Rheumatol Int Validation Studies To develop a disease activity index for patients with uveitis (UVEDAI) encompassing the relevant domains of disease activity considered important among experts in this field. The steps for designing UVEDAI were: (a) Defining the construct and establishing the domains through a formal judgment of experts, (b) A two-round Delphi study with a panel of 15 experts to determine the relevant items, (c) Selection of items: A logistic regression model was developed that set ocular inflammatory activity as the dependent variable. The construct “uveitis inflammatory activity” was defined as any intraocular inflammation that included external structures (cornea) in addition to uvea. Seven domains and 15 items were identified: best-corrected visual acuity, inflammation of the anterior chamber (anterior chamber cells, hypopyon, the presence of fibrin, active posterior keratic precipitates and iris nodules), intraocular pressure, inflammation of the vitreous cavity (vitreous haze, snowballs and snowbanks), central macular edema, inflammation of the posterior pole (the presence and number of choroidal/retinal lesions, vascular inflammation and papillitis), and global assessment from both (patient and physician). From all the variables studied in the multivariate model, anterior chamber cell grade, vitreous haze, central macular edema, inflammatory vessel sheathing, papillitis, choroidal/retinal lesions and patient evaluation were included in UVEDAI. UVEDAI is an index designed to assess the global ocular inflammatory activity in patients with uveitis. It might prove worthwhile to motorize the activity of this extraarticular manifestation of some rheumatic diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00296-016-3593-1) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-11-04 2017 /pmc/articles/PMC5357298/ /pubmed/27815703 http://dx.doi.org/10.1007/s00296-016-3593-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Validation Studies Pato, Esperanza Martin-Martinez, Mª Auxiliadora Castelló, Adela Méndez-Fernandez, Rosalía Muñoz-Fernández, Santiago Cordero-Coma, Miguel Martinez-Costa, Lucia Valls, Elia Reyes, Miguel Francisco, Félix Esteban, Mar Fonollosa, Alex Sanchez-Alonso, Fernando Fernández-Espartero, Cruz Diaz-Valle, Teresa Carrasco, José Miguel Beltran-Catalán, Emma Hernández-Garfella, Marisa Hernández, María Victoria Pelegrin, Laura Blanco, Ricardo Diaz-Valle, David Development of an activity disease score in patients with uveitis (UVEDAI) |
title | Development of an activity disease score in patients with uveitis (UVEDAI) |
title_full | Development of an activity disease score in patients with uveitis (UVEDAI) |
title_fullStr | Development of an activity disease score in patients with uveitis (UVEDAI) |
title_full_unstemmed | Development of an activity disease score in patients with uveitis (UVEDAI) |
title_short | Development of an activity disease score in patients with uveitis (UVEDAI) |
title_sort | development of an activity disease score in patients with uveitis (uvedai) |
topic | Validation Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357298/ https://www.ncbi.nlm.nih.gov/pubmed/27815703 http://dx.doi.org/10.1007/s00296-016-3593-1 |
work_keys_str_mv | AT patoesperanza developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT martinmartinezmaauxiliadora developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT castelloadela developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT mendezfernandezrosalia developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT munozfernandezsantiago developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT corderocomamiguel developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT martinezcostalucia developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT vallselia developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT reyesmiguel developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT franciscofelix developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT estebanmar developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT fonollosaalex developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT sanchezalonsofernando developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT fernandezesparterocruz developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT diazvalleteresa developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT carrascojosemiguel developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT beltrancatalanemma developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT hernandezgarfellamarisa developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT hernandezmariavictoria developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT pelegrinlaura developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT blancoricardo developmentofanactivitydiseasescoreinpatientswithuveitisuvedai AT diazvalledavid developmentofanactivitydiseasescoreinpatientswithuveitisuvedai |